Overview
NICE has developed a medtech innovation briefing (MIB) on PredictSURE IBD for inflammatory bowel disease prognosis: ulcerative colitis.
NICE has also published diagnostics guidance on PredictSURE IBD and IBDX to guide treatment of Crohn’s disease.
This advice replaces NICE medtech innovation briefing 178.